CYV
CERYVYN FPO [CYV]
Healthcare · ASX Small Cap
$0.0110 -8.3%
Updated 3 Sep 2026 · Signals refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Get alerts when CYV triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI is looking oversold — historically a spot where stocks tend to bounce
- Volume surging at 3.9x normal while price falls — heavy selling pressure
- On a tear — up 10.0% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
- Critical cash runway (1.0 quarters)
- 4C filed 2026-07-26
- Revenue in sharp decline (-100%)
- Near 52-week low (0% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 98% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (1.12%/day)
- Pre-revenue company — Altman Z-Score not applicable
- Penny stock risk ($0.012)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -100% — the top line is shrinking
Ask Scout AI about CYV
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Proposed issue of securities - CYV
NONE Appendix 4G and Corporate Governance Statement
NONE Notification regarding unquoted securities - CYV
LOW Appendix 4E and 2026 Annual Report
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-09-01 | Proposed issue of securities - CYV |
| 2026-08-31 | Appendix 4G and Corporate Governance Statement |
| 2026-08-31 | Appendix 4E and 2026 Annual Report PRICE SENSITIVE |
| 2026-08-21 | Notification regarding unquoted securities - CYV |
| 2026-07-26 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$16.4M
Market Cap
4.7M
Avg Volume
3.9x
Vol Ratio
$0.01 — $0.60
52-Week Range
0.3%
Short Interest
1 qtrs
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 82% |
| L | Leader vs Laggard | laggard | RS: -11 |
| I | Institutional Sponsorship | weak | Inst: 5% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track CYV and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required